Genetic alternations of p73 are infrequent but may occur in early stage hepatocellular carcinoma

Cheng Yuan Peng, Sun Lung Tsai, Chau Ting Yeh, Shao Pi Hung, Miin Fu Chen, Tse Ching Chen, Chia Ming Chu, Yun Fan Liaw*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

16 Scopus citations


p73, a structural homologue of the tumor suppressor gene, p53, has recently been identified and mapped to chromosome 1p36, where genomic loss of heterozygosity (LOH) often occurs in human hepatocellular carcinoma (HCC). To determine whether p73 is involved in the development of HCC and whether there is an inverse correlation between the mutations of p73 and p53, we examined 22 paired tumors/noncancerous liver tissues for allelic expression LOH and mutation of p73 and for mutation of p53. p73 was biallelically expressed in noncancerous liver tissues and in 7 out of the 8 informative tumors. One tumor tissue expressed only a single allele. LOH of p73 was found in 2 out of the 11 (18%) informative cases. A tumor-specific five-nucleotide deletion mutation causing a reading ffameshift/early truncation of p73 DNA-binding domain was found, in which case no concomitant mutation in the DNA-binding domain of p53 was identified. Nine out of the 22 cases (41%) contained tumor-specific mutations in the DNA-binding domain of p53. Two of the three cases with p73 genetic alternations had a tumor size of less than 2 centimeters. These results suggest that p73 is a biallelically expressed gene in the liver and that allelic loss and mutation of p73 is infrequent and may occur early in HCC. p73 is unlikely to be the putative tumor suppressor gene located at chromosome 1p36 in HCC.

Original languageEnglish
Pages (from-to)1487-1492
Number of pages6
JournalAnticancer Research
Issue number3 A
StatePublished - 2000


  • Chromosome 1p36
  • Hepatocellular carcinoma
  • Loss of heterozygosity
  • Tumor suppressor gene
  • p73


Dive into the research topics of 'Genetic alternations of p73 are infrequent but may occur in early stage hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this